8-K current report · filed Aug 25, 2026

Septerna, Inc. (SEPN) 8-K Current Report: August 25, 2026

Item 8.01Item 7.01SEPN overview

Short answer

Septerna, Inc. (SEPN) filed an 8-K current report with the SEC on August 25, 2026 reporting Item 8.01 (Other Events), Item 7.01 (Regulation FD Disclosure). Septerna appointed Rajiv Patni, M.D., an industry veteran, as Chief Medical Officer.

Septerna, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Septerna appointed Rajiv Patni, M.D., an industry veteran, as Chief Medical Officer
  • Leadership change adds senior clinical development expertise, potentially supporting pipeline advancement and regulatory execution
  • Investors should assess Patni’s track record and the company’s expected clinical priorities in Exhibit 99.1

Item 8.01 · Other Events

  • Rajiv Patni, M.D. appointed Chief Medical Officer effective August 24, 2026
  • Senior leadership addition relevant to Septerna’s clinical-development strategy and medical oversight
  • Appointment may influence trial execution, regulatory engagement, and pipeline prioritization

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Septerna, Inc. 8-K filings

Get the next SEPN 8-K as it lands

Follow SEPN for push alerts, or ask the research agent what this filing means.